Top Markets
Coin of the day
PsyRX CNS Bio-Tech Ltd PsyRX CNS Bio-Tech Ltd

PsyRX CNS Bio-Tech Ltd

PSRX
Rank in Stocks #42513
PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based... PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based pharmaceuticals and healthcare products. Its portfolio encompasses drugs targeting diverse medical conditions, personalized cannabinoid formulations, and CBD-infused skincare along with food supplements. Established in 2019, the company, formerly known as Cannabotech LTD, is headquartered in Rishon LeZion, Israel.
Share Price
$0.24869863
Last synced: 2026-08-12
Market Cap
$1.02K
Change (1 day)
6.37%
Change (1 year)
-
Country
IL
Trade PsyRX CNS Bio-Tech Ltd (PSRX)

Category

P/E ratio for PsyRX CNS Bio-Tech Ltd (PSRX)
P/E ratio as of 2026 TTM: 0
According to PsyRX CNS Bio-Tech Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for PsyRX CNS Bio-Tech Ltd from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.